A Study of Rovalpituzumab Tesirine to Study Cardiac Ventricular Repolarization in Subjects With Small Cell Lung Cancer
Clinical trial NCT02874664 · COMPLETED
Trial details
- NCT number
- NCT02874664
- Sponsor
- Stemcentrx
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2018-09-12
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.